STOCK TITAN

QXO, Inc. (NYSE: QXO) files 95,876,547-share resale prospectus

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

QXO, Inc. filed a prospectus supplement covering the resale by certain selling stockholders of 95,876,547 shares of common stock and 192,533 shares of Series C Convertible Perpetual Preferred Stock. The common shares include 13,066,710 shares already outstanding and 82,809,837 shares issuable upon conversion of the Preferred Stock.

The company also filed a legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP as Exhibit 5.1, along with the related consent and an Inline XBRL cover page data file.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Common shares registered for resale 95,876,547 shares Covered by prospectus supplement filed April 29, 2026
Outstanding common shares included 13,066,710 shares Portion of registered common stock already outstanding
Common shares issuable on conversion 82,809,837 shares Common stock issuable upon conversion of Series C Preferred Stock
Series C Preferred Stock registered 192,533 shares Preferred Stock covered for resale by selling stockholders
Preferred Stock dividend rate 5.50% Series B Mandatory Convertible Preferred Stock referenced in NYSE listing
Par value common stock $0.00001 per share Par value of QXO common stock listed on NYSE
Par value preferred stock $0.001 per share Par value of 5.50% Series B Mandatory Convertible Preferred Stock
prospectus supplement regulatory
"filed with the Securities and Exchange Commission a prospectus supplement to the prospectus included"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
registration statement on Form S-3ASR regulatory
"the Company’s registration statement on Form S-3ASR (File No. 333-281084)"
A registration statement on Form S-3ASR is a pre-approved filing used by well-established public companies to register securities they may sell over time, with the paperwork becoming effective automatically so offerings can begin quickly. For investors, it matters because it lets a company raise money or issue stock or debt on short notice — like a company keeping a ready-to-use credit line — which can dilute existing shares or change the company’s cash position rapidly.
Series C Convertible Perpetual Preferred Stock financial
"shares of common stock issuable upon the conversion of shares of the Company’s Series C Convertible Perpetual Preferred Stock"
Mandatory Convertible Preferred Stock financial
"5.50% Series B Mandatory Convertible Preferred Stock, par value $0.001 per share"
A mandatory convertible preferred stock is a type of investment that pays regular income like a preferred share but is designed to automatically turn into a set number of common shares at a future date, much like a timed coupon that becomes company ownership. It matters to investors because it combines a near-term income stream with a guaranteed future increase in the company’s share count, which can dilute existing owners and change earnings-per-share and voting balance.
selling stockholders financial
"covering the resale by certain selling stockholders named therein"
Selling stockholders are existing owners of a company's shares who are offering some or all of their holdings for sale, often as part of a public offering or secondary transaction. For investors this matters because such sales increase the number of shares available to buy, can signal how confident current owners are about future prospects, and may put short-term pressure on the stock price similar to more tickets being released for a popular event.
false 0001236275 0001236275 2026-04-29 2026-04-29 0001236275 QXO:CommonStockParValue0.00001PerShareMember 2026-04-29 2026-04-29 0001236275 QXO:DepositarySharesEachRepresenting120thInterestInShareOf5.50SeriesBMandatoryConvertiblePreferredStockParValue0.001PerShareMember 2026-04-29 2026-04-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 29, 2026

QXO, INC.

(Exact name of registrant as specified in its charter)

Delaware 001-38063 16-1633636
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

 

Five American Lane
Greenwich, Connecticut
(Address of principal executive offices)
06831
(Zip Code)

 

Registrant’s telephone number, including area code: 888-998-6000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common stock, par value $0.00001 per share   QXO   New York Stock Exchange
Depositary Shares, each representing a 1/20th interest in a share of 5.50% Series B Mandatory Convertible Preferred Stock, par value $0.001 per share   QXO.PRB   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

   

 

Item 8.01Other Events.

On April 29, 2026, QXO, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR (File No. 333-281084), filed with the SEC on July 29, 2024 (the “Registration Statement”), covering the resale by certain selling stockholders named therein of (i) 95,876,547 shares of the Company’s common stock, consisting of (A) 13,066,710 shares of common stock outstanding and (B) 82,809,837 shares of common stock issuable upon the conversion of shares of the Company’s Series C Convertible Perpetual Preferred Stock (“Preferred Stock”), and (ii) 192,533 shares of Preferred Stock.

 

A copy of the legal opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP relating to the shares is filed herewith as Exhibit 5.1 and is incorporated herein by reference, and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.

 

Item 9.01Financial Statements and Exhibits.

(d)       Exhibits.

Exhibit No.

 

Description

5.1  

Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP.

23.1  

Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1).

104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

   

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 29, 2026

 

  QXO, INC.  
     
         
By: /s/ Christopher Signorello  
    Name: Christopher Signorello  
    Title: Chief Legal Officer  

 

 

 

 

   

FAQ

What did QXO (QXO) disclose in its April 29, 2026 filing?

QXO, Inc. disclosed that it filed a prospectus supplement covering the resale of common and preferred shares by certain selling stockholders. It also filed a supporting legal opinion and related consent from Paul, Weiss, Rifkind, Wharton & Garrison LLP.

How many QXO (QXO) common shares are covered by the new prospectus supplement?

The prospectus supplement covers 95,876,547 shares of QXO’s common stock. This total includes 13,066,710 shares already outstanding and 82,809,837 shares of common stock issuable upon conversion of the company’s Series C Convertible Perpetual Preferred Stock.

How many shares of QXO (QXO) Series C Convertible Perpetual Preferred Stock are included?

The prospectus supplement covers 192,533 shares of QXO’s Series C Convertible Perpetual Preferred Stock. These preferred shares are in addition to the common stock registered for resale by the selling stockholders named in the prospectus supplement.

What is the purpose of QXO (QXO) filing a prospectus supplement on Form S-3ASR?

QXO filed a prospectus supplement to its Form S-3ASR registration statement to cover resales of specified common and preferred shares by certain selling stockholders. This allows those holders to resell registered securities under the existing shelf registration framework.

What securities of QXO (QXO) are listed on the New York Stock Exchange?

QXO lists its common stock, par value $0.00001 per share, under the symbol QXO on the New York Stock Exchange. It also lists depositary shares representing a 1/20th interest in a share of 5.50% Series B Mandatory Convertible Preferred Stock under the symbol QXO.PRB.

Filing Exhibits & Attachments

5 documents